Compumedics Limited

ASX:CMP.AX

0.305 (AUD) • At close July 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 50.26242.40837.75635.7435.06941.50537.00234.41737.54433.49529.06827.1527.91531.26532.61138.18138.58236.87138.87738.49933.96332.05619.74716.639000
Cost of Revenue 23.65120.81818.43616.57817.05716.73615.81515.36617.61515.45314.55413.3314.09613.16813.27416.20516.57415.38418.02417.86414.5814.177.9250000
Gross Profit 26.06821.5919.3219.16218.01224.76921.18719.05119.92918.04214.51413.8213.81918.09719.33721.97622.00821.48720.85320.29319.38318.26811.82216.639000
Gross Profit Ratio 0.5190.5090.5120.5360.5140.5970.5730.5540.5310.5390.4990.5090.4950.5790.5930.5760.570.5830.5360.5270.5710.570.5991000
Reseach & Development Expenses 5.7425.4614.0564.3883.8435.3195.1075.8815.7474.7575.1584.3694.6354.7024.8764.8664.5884.67.3127.8836.56.7082.8540.871000
General & Administrative Expenses 7.0826.4125.6446.1165.9276.0125.4815.6415.2624.7974.6034.5284.4264.4855.4654.995.5524.2774.7985.0193.4864.233.9742.684000
Selling & Marketing Expenses 14.05613.2519.4838.268.9988.4717.5176.8936.4386.8015.8445.9056.6317.4328.0159.75610.8510.5739.97210.3236.8426.9154.9072.862000
SG&A 21.13819.66315.12714.37614.92514.48312.99812.53411.711.59810.44710.38111.05713.7413.47512.22116.40214.8514.7715.34210.32811.1458.8815.547000
Other Expenses 1.5701.2121.457-0.6870.7930.6370.6360.760.999-1.072-1.649-1.858-0.3560.7363.2851.0121.953-1.348-2.9322.5540.1480.10110.221-0.1181.9740.12
Operating Expenses 28.4525.12420.39520.22118.01220.02118.32519.05119.92918.04214.51413.8213.81918.0919.08720.05422.00221.40320.73320.29319.38317.88711.7816.639-0.1181.9740.12
Operating Income -0.269-3.5340.1370.398-0.7564.5392.5751.4183.2112.6861.583-0.868-2.974-1.3110.3842.8820.461.498-2.293-3.9282.094-20.343-1.919-1.183-0.1181.974-0.12
Operating Income Ratio -0.005-0.0830.0040.011-0.0220.1090.070.0410.0860.080.054-0.032-0.107-0.0420.0120.0750.0120.041-0.059-0.1020.062-0.635-0.097-0.071000
Total Other Income Expenses Net 0.749-3.1851.5610.378-6.7470.3390.6251.5231.8191.1711.423-0.4141.1870.5440.03-0.1550.223-1.3750.6980.0310.3151.378-0.5773.984-0.158-0.1111.362
Income Before Tax 0.48-6.7191.6980.776-7.5035.0873.4871.1062.8062.0110.972-1.282-1.787-0.7670.4142.7290.6830.123-1.595-3.8972.409-18.965-2.4962.801-0.2761.8631.242
Income Before Tax Ratio 0.01-0.1580.0450.022-0.2140.1230.0940.0320.0750.060.033-0.047-0.064-0.0250.0130.0710.0180.003-0.041-0.1010.071-0.592-0.1260.168000
Income Tax Expense 0.818-0.5970.341-0.222-1.6651.0710.703-0.199-0.4670.0410.0630.2071.042-0.84801.485-0.07300-3.8972.409-18.965-2.4952.801-0.2761.8631.242
Net Income -0.338-6.1221.3570.998-5.8384.0162.7841.3053.2731.970.909-1.489-2.8290.0810.4142.7270.7560.123-1.595-3.8982.397-18.557-1.8981.971-0.0951.2150.788
Net Income Ratio -0.007-0.1440.0360.028-0.1660.0970.0750.0380.0870.0590.031-0.055-0.1010.0030.0130.0710.020.003-0.041-0.1010.071-0.579-0.0960.118000
EPS -0.002-0.0350.0080.006-0.0330.0230.0160.0070.0190.0120.005-0.009-0.0180.0010.0030.0170.0050.001-0.011-0.0280.017-0.13-0.0140.017-0.0010.0090.006
EPS Diluted -0.002-0.0350.0080.006-0.0330.0230.0160.0070.0190.0120.005-0.009-0.0180.0010.0030.0170.0050.001-0.011-0.0280.017-0.13-0.0140.017-0.0010.0090.006
EBITDA 2.789-5.0543.3112.563-5.4195.7764.1762.6984.8464.062.9690.342-0.1560.6021.5293.691.9491.449-0.007-2.3513.137-0.367-0.4294.223-0.1181.9741.383
EBITDA Ratio 0.055-0.1190.0880.072-0.1550.1390.1130.0780.1290.1210.1020.013-0.0060.0190.0470.0970.0510.039-0-0.0610.092-0.011-0.0220.254000